A Survey of Sexual Function in Schizophrenic Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01835522|
Recruitment Status : Withdrawn
First Posted : April 19, 2013
Last Update Posted : August 4, 2015
The goal of this study is to survey patients with a diagnosis of schizophrenia to determine if there is a relationship between self-reported sexual function and treatment with antipsychotic medication.
Hypotheses: 1. Patients on typical antipsychotics will rate their sexual function as lower than those on atypical agents. 2. Patients on multiple antipsychotics will rate their sexual function as lower than those on a single agent.
|Condition or disease|
Show Detailed Description
|Study Type :||Observational|
|Actual Enrollment :||0 participants|
|Official Title:||A Survey of Sexual Function in Schizophrenic Patients|
|Study Start Date :||July 2009|
|Actual Primary Completion Date :||July 2014|
|Actual Study Completion Date :||July 2014|
- Level of sexual functioning [ Time Frame: 4 weeks ]
Patient's level of sexual functioning will be measured at the time of assessment. Two different scales will be used depending on the gender of the patient.
IIEF (International Index of Erectile Function Questionnaire for men) will be used for men. This 15-item questionnaire is a brief, multidimensional instrument for assessing the key dimensions of sexual function in men. It assesses male function and quality of life.
FSFI (Female Sexual Function Index) will be used for women. This 19-item questionnaire is a brief, multidimensional self-report instrument for assessing the key dimensions of sexual function in women. It assesses female function and quality of life.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01835522
|United States, New York|
|Beth Israel Medical Center|
|New York, New York, United States, 10003|
|Principal Investigator:||Dennis Lin, MD||Beth Israel Medical Center|